Emeritus Professor Kathie Knights

Activities

Activities per year 2001 2001 2002 2003 2004 2004

• 6 Oral presentation

Activities per year

Search results

• Kinetic characterisation of S-naproxen glucuronidation by human kidney cortical microsomes and recombinant UGT 1A9 and UGT2B7

  Kathie Knights (Speaker), Voula Gaganis (Speaker), Kushari Burns (Speaker), David Elliot (Speaker) & John Miners (Speaker)

  1 Jan 2004

  Activity: Talk or presentation types › Oral presentation

• NSAID-arachidonic acid interactions are intimately linked to the nephrotoxic potential of NAIDs during renal ischaemia

  Voula Gaganis (Speaker), John Miners (Speaker) & Kathie Knights (Speaker)

  30 Nov 2003

  Activity: Talk or presentation types › Oral presentation

• Unsaturated fatty acids: potent inhibitors of renal UDP-glucuronosyltransferases (UGT)

  Voula Gaganis (Speaker), B Sallustio (Speaker), John Miners (Speaker) & Kathie Knights (Speaker)

  19 Aug 2003

  Activity: Talk or presentation types › Oral presentation

• Fatty acids are potent inhibitors of 4-methylumbelliferone glucuronidation by human renal and recombinant UDP-glucuronosyltransferases

  Voula Gaganis (Speaker), John Miners (Speaker), Kathie Knights (Speaker) & B Sallustio (Speaker)

  7 Jul 2002

  Activity: Talk or presentation types › Oral presentation

• The effect of fatty acids on the glucuronidation of 4-methyl-um-belliferone (4-MU) by human kidney cortical microsomes

  Kathie Knights (Speaker), Voula Gaganis (Speaker), John Miners (Speaker) & B Sallustio (Speaker)

  7 Oct 2001 → 11 Oct 2001

  Activity: Talk or presentation types › Oral presentation

• Role of fatty acids as substrates for renal UDP-glucuronosyltransferases and inhibitors of 4-methylumbelliferone glucuronidation by human kidney cortical microsomes

  Voula Gaganis (Speaker), B Sallustio (Speaker), John Miners (Speaker) & Kathie Knights (Speaker)

  3 Dec 2001

  Activity: Talk or presentation types › Oral presentation